{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disease&page=49", "query": { "condition": "Retinal Disease", "page": 49 }, "page_size": 10 }, "pagination": { "page": 49, "page_size": 10, "total_count": 1620, "total_pages": 162, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disease&page=50&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disease&page=48&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T18:37:55.041Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05532735", "title": "Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Retinal Vein Occlusion" ], "interventions": [ { "name": "ANXV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Annexin Pharmaceuticals AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2022-08-24", "completion_date": "2024-11-11", "has_results": false, "last_update_posted_date": "2024-12-11", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 7, "location_summary": "West Monroe, Louisiana • Hagerstown, Maryland • Tulsa, Oklahoma + 4 more", "locations": [ { "city": "West Monroe", "state": "Louisiana" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Bellaire", "state": "Texas" }, { "city": "McAllen", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05532735" }, { "nct_id": "NCT03475173", "title": "New Non-invasive Modalities for Assessing Retinal Structure and Function", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ischemic Optic Neuropathy", "Branch Retinal Artery Occlusion", "Hemianopia", "Leber Hereditary Optic Neuropathy", "Acute Zonal Occult Outer Retinopathy" ], "interventions": [ { "name": "LSFG-NAVI", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Randy Kardon", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 500, "start_date": "2019-05-06", "completion_date": "2028-03-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03475173" }, { "nct_id": "NCT04656561", "title": "A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Geographic Atrophy" ], "interventions": [ { "name": "ANX007", "type": "DRUG" }, { "name": "Sham comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Annexon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 270, "start_date": "2021-02-26", "completion_date": "2023-09-13", "has_results": true, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 45, "location_summary": "Phoenix, Arizona • Bakersfield, California • Beverly Hills, California + 39 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Mountain View", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04656561" }, { "nct_id": "NCT02859766", "title": "Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Macular Degeneration" ], "interventions": [ { "name": "Abicipar pegol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 30, "start_date": "2016-12-07", "completion_date": "2017-10-20", "has_results": false, "last_update_posted_date": "2018-02-08", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 18, "location_summary": "Gilbert, Arizona • Arcadia, California • Beverly Hills, California + 15 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02859766" }, { "nct_id": "NCT03330353", "title": "Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "PSP - Progressive Supranuclear Palsy", "PD - Parkinson's Disease", "AD - Alzheimer's Disease", "ALS (Amyotrophic Lateral Sclerosis)" ], "interventions": [ { "name": "Pupillometry", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 56, "start_date": "2017-11-01", "completion_date": "2019-10-01", "has_results": false, "last_update_posted_date": "2017-11-07", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03330353" }, { "nct_id": "NCT00003273", "title": "Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain and Central Nervous System Tumors", "Neuroblastoma", "Retinoblastoma", "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "temozolomide", "type": "DRUG" }, { "name": "thiotepa", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "autologous bone marrow transplantation", "type": "PROCEDURE" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "10 Years", "sex": "ALL", "summary": "Up to 10 Years" }, "enrollment_count": 0, "start_date": "1997-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-12-03", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 17, "location_summary": "Honolulu, Hawaii • Scarborough, Maine • Grand Rapids, Michigan + 11 more", "locations": [ { "city": "Honolulu", "state": "Hawaii" }, { "city": "Scarborough", "state": "Maine" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003273" }, { "nct_id": "NCT01806402", "title": "Evaluation of OCT Measurements", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Assess Eye Measurements in Patients Having Retina Pathology or Glaucoma" ], "interventions": [], "intervention_types": [], "sponsor": "Optovue", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2013-02", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2014-01-22", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 3, "location_summary": "Daly City, California • Petaluma, California • Walnut Creek, California", "locations": [ { "city": "Daly City", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01806402" }, { "nct_id": "NCT03034772", "title": "Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Neovascular Age-related Macular Degeneration", "Wet Macular Degeneration" ], "interventions": [ { "name": "Dorzolamide-timolol", "type": "DRUG" }, { "name": "Artificial tears", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wills Eye", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 52, "start_date": "2017-02-08", "completion_date": "2019-07-05", "has_results": true, "last_update_posted_date": "2020-06-19", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 5, "location_summary": "Palo Alto, California • Boston, Massachusetts • Royal Oak, Michigan + 2 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03034772" }, { "nct_id": "NCT00000673", "title": "A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cytomegalovirus Retinitis", "HIV Infections" ], "interventions": [ { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "13 Years to 65 Years" }, "enrollment_count": 38, "start_date": null, "completion_date": "1993-05", "has_results": false, "last_update_posted_date": "2021-10-27", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 2, "location_summary": "Miami, Florida • St Louis, Missouri", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000673" }, { "nct_id": "NCT05215782", "title": "Eye to Brain Connection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Optina Diagnostics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 65, "start_date": "2022-03-14", "completion_date": "2023-03-16", "has_results": false, "last_update_posted_date": "2023-03-24", "last_synced_at": "2026-10-30T18:37:55.041Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05215782" } ] }